Dosing chart / Growth hormone
GHRP-2 vs GHRP-6
Dose, schedule, route and approval status side by side.
Reference only, not medical advice. Doses marked FDA-approved come from the US prescribing label. Doses marked Not approved are ranges reported from small studies or community use and have not been established as safe or effective in humans. Check anything here with a licensed clinician before acting on it. Read the full disclaimer.
| GHRP-2 | GHRP-6 | |
|---|---|---|
| Status | Not approved | Not approved |
| Also known as | pralmorelin | – |
| Typical dose | 100–300 mcg | 100–300 mcg |
| How often | Daily, 1–3 times | Daily, 1–3 times |
| Schedule | One to three times daily. | One to three times daily. |
| Daily equivalent | 100–900 mcg/day | 100–900 mcg/day |
| Route | Subcutaneous | Subcutaneous |
| Duration | 8–12 weeks reported | 8–12 weeks reported |
| Notes | Used in Japan as a single-dose diagnostic test for growth hormone deficiency, not as a treatment. Increases appetite and cortisol. | Strongly increases hunger. Doses are community-reported. |
This page sets the two chart entries next to each other. It does not say which is better or whether either is right for you. Read member experiences on the GHRP-2 and GHRP-6 pages.
Advertisement